Accueil › Cancer de l'ovaire › Virginie › Arlington
Essais cliniques pour Cancer de l'ovaire à Arlington, VA
46 études pour Cancer de l'ovaire recherchent des participants dans et autour de Arlington (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Recrutement en coursPhase 2
- Inova Fairfax Hospital, Falls Church · à 4 mi
- Inova Schar Cancer Institute, Fairfax · à 11 mi
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Recrutement en coursPhase 1/2
- Virginia Cancer Specialists, Fairfax · à 11 mi
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1
- Inova Schar Cancer Institute, Fairfax · à 11 mi
- NEXT Virginia, Fairfax · à 11 mi
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Recrutement en coursPhase 1
- NEXT Virginia, Fairfax · à 11 mi
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Recrutement en coursPhase 2
- Next Virginia /ID# 279684, Fairfax · à 11 mi
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
Recrutement en coursPhase 1
- Next Virginia /ID# 278607, Fairfax · à 11 mi
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Recrutement en coursPhase 1
- Site 04, Fairfax · à 11 mi
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
Recrutement en coursPhase 1/2
- NEXT Virginia, Fairfax · à 11 mi
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Recrutement en coursPhase 2
- Site 0322 - Inova Schar Cancer Institute, Fairfax · à 11 mi
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Recrutement en coursPhase 2
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 276456, Fairfax · à 11 mi
Study of AVZO-021 in Patients With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · à 11 mi
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Recrutement en coursPhase 1/2
- NEXT Oncology Virginia, Fairfax · à 11 mi
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Recrutement en coursPhase 1
- Virginia Cancer Specialists, Fairfax · à 11 mi
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Recrutement en coursPhase 1/2
- NEXT Oncology, Fairfax · à 11 mi
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Recrutement en coursPhase 3
- Virginia Cancer Specialists (VCS) ( Site 8012), Fairfax · à 11 mi
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Recrutement en coursPhase 2
- Virginia Cancer Specialists, Fairfax · à 11 mi
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Recrutement en coursPhase 3
- Inova Schar Cancer Institute, Fairfax · à 11 mi
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Recrutement en coursPhase 1/2
- Inova Schar Cancer Institute, Fairfax · à 11 mi
- Next Oncology Virginia, Fairfax · à 11 mi
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Recrutement en coursPhase 1
- Virginia Cancer Specialists, Fairfax · à 11 mi
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
Recrutement en coursPhase 1
- NEXT Oncology, Fairfax · à 11 mi
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Recrutement en coursPhase 3
- Virginia Cancer Specialists (VCS) ( Site 8011), Fairfax · à 11 mi
The Vanguard Study: Testing a New Way to Screen for Cancer
Recrutement en coursVolontaires sains bienvenus
- Inova Schar Cancer Institute, Fairfax · à 11 mi
- Inova Fair Oaks Hospital, Fairfax · à 11 mi
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Recrutement en coursPhase 1
- Inova Schar Cancer Institute, Falls Church · à 4 mi
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Recrutement en coursPhase 1/2
- Research Site, Fairfax · à 11 mi
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Recrutement en coursPhase 1
- Normunity Investigational Site, Fairfax · à 11 mi
A Study of PHST001 in Advanced Solid Tumors
Recrutement en coursPhase 1
- NEXT Oncology - Virginia, Fairfax · à 11 mi
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Recrutement en cours
- Inova Fairfax Hospital, Falls Church · à 4 mi
- Inova Schar Cancer Institute, Fairfax · à 11 mi
- Inova Fair Oaks Hospital, Fairfax · à 11 mi
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- Clinical Trial Site, Fairfax · à 11 mi
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · à 11 mi
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Recrutement en coursPhase 1/2
- Virginia Cancer Specialists, Fairfax · à 11 mi
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Recrutement en coursPhase 1/2
- USOR Virginia Cancer Specialists, Fairfax · à 11 mi
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1/2
- Virginia Cancer Specialists, Fairfax · à 11 mi
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Recrutement en coursPhase 1
- NEXT Virginia, Fairfax · à 11 mi
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Recrutement en coursPhase 2
- 522, Fairfax · à 11 mi
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · à 11 mi
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Recrutement en coursPhase 1
- Virginia Cancer Specialists, Fairfax · à 11 mi
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
Recrutement en coursPhase 1
- NEXT Virginia, Fairfax · à 11 mi
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Recrutement en coursPhase 1/2
- NEXT Oncology Virginia, Fairfax · à 11 mi
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- NEXT, Fairfax · à 11 mi
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Recrutement en coursPhase 3
- Inova Schar Cancer Institute, Fairfax · à 11 mi
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Recrutement en coursPhase 1
- NEXT Oncology Virginia, Fairfax · à 11 mi
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Recrutement en coursPhase 1/2
- Virginia Cancer Specialists, Fairfax · à 11 mi
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Recrutement en coursPhase 1
- Virginia Cancer Specialists, Fairfax · à 11 mi
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
Recrutement en coursPhase 1
- NEXT Oncology, Fairfax · à 11 mi
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Recrutement en coursPhase 1
- Dren Investigational Site, Fairfax · à 11 mi
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
Recrutement en coursPhase 1
- Next Oncology, Virginia Cancer Specialists, Fairfax · à 11 mi
Essais pour Cancer de l'ovaire dans d'autres villes
- Houston, TX89 études
- New York City, NY69 études
- Boston, MA61 études
- Los Angeles, CA50 études
- Nashville, TN49 études
- Philadelphia, PA44 études
- Columbus, OH39 études
- St. Louis, MO38 études
- Chicago, IL36 études
- San Antonio, TX31 études
- Cleveland, OH30 études
- Pittsburgh, PA30 études
Autres études à Arlington
- Cancer du poumon non à petites cellules104 études
- Cancer métastatique53 études
- Cancer colorectal52 études
- Cancer (tous types)48 études
- Cancer du sein46 études
- Cancer du poumon41 études
- Cancer de l'endomètre39 études
- Cancer du pancréas33 études
- Carcinome épidermoïde de la tête et du cou26 études
- Cancer bronchique à petites cellules23 études
- Cancer du sein triple négatif20 études
- Cancer de l'estomac20 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.